Peregrine Pharmaceuticals (PPHM) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts PPHM Hot Sheet
Price: $0.61 --0%
Financial Fact:
Cost of contract manufacturing: 3.06M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Cost of contract manufacturing: 3.06M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Peregrine Pharmaceuticals (NASDAQ: PPHM) reported Q4 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $4.25 million versus the consensus estimate of $3.57 million.
For earnings history and earnings-related data on Peregrine Pharmaceuticals (PPHM) click here.
For earnings history and earnings-related data on Peregrine Pharmaceuticals (PPHM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
